36.4
RedHill Biopharma Ltd.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY24
millions USD
FY21:
FY22:
28.5
FY23:
3.07
FY24:
4.85
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−81.1
FY22:
−42.8
FY23:
−16.7
FY24:
−14.6
FY25:
−7.94
(positive)
Change from FY21 to FY22
millions USD
FY21:
−63.0
FY22:
−35.6
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY22
millions USD
FY21:
−97.7
FY22:
−71.7
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−97.7
FY22:
−71.7
FY23:
23.9
FY24:
−8.27
FY25:
−0.43
All amounts in millions USD